Alkaloids Bioactives
India 9 employees Updated 9 July 2026
Alkaloids Bioactives is an API manufacturer based in India. It holds one active US drug master file. Its GMP standing is certified by US FDA. Its most recent recorded inspection, by US FDA, closed on 23 February 2024 as NAI. Customs aggregates show $2.8M of exports covering 50 molecules to 21 destinations in 2025.
1
registered plants
1 with an FDA FEI number
0
filings
across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Inspections
3 of 3 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.
Inspection history
- 23 February 2024 NAI US FDA
- 9 June 2016 NAI US FDA
- 25 February 2011 VAI US FDA
NAI means no action indicated, VAI means voluntary action indicated, and OAI means
official action indicated.
Registered plants
| Site | FDA FEI |
| Medchal-Malkajgiri, India | 3004443761 |
What they file, and where
Also appears on these molecule pages
Filings and GMP by regulator
| Regulator | Filings | GMP certificates |
| US FDA | None | 1 |
Scale
| Year | Revenue | Exports | Destinations |
| 2026 YTD | Not reported | $745K | 12 |
| 2025 | Not reported | $2.8M | 21 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Comparing suppliers?
Choose your molecules and target markets. Alkaloids Bioactives comes back tiered against every other
supplier able to file there.
Start for free No sales call.
Open risk flags
- The most recent inspection outcome was NAI, on 23 February 2024.
Sources on this page
- FDA
- Drug master files, establishment registration, inspection classifications
- EDQM
- Certificates of suitability
- EudraGMDP and national regulators
- GMP certificates
- Customs aggregates
- Export values, molecule and destination counts